AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
USA-based biotechnology firm Advaxis says that it has developed a new family of vaccines which have the potential to change the way in which cancer is treated. The company explained that its Lovaxin range of products are composed of genetically ...